Robert Rosenheck, MD

Academic detailing coupled with a provider survey did not decrease the rate of new prescriptions for costly, on-patent second-generation antipsychotics in a VA hospital.

The majority of patients prescribed antipsychotic medications in state Medicaid programs are taking these agents for off-label indications.